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Abstract
Background: Collision tumors of the thyroid gland are a rare entity. We present a case of a
follicular variant of papillary carcinoma and squamous carcinoma in the thyroid. To the best of our
knowledge, this is the first documentation of a collision tumor with a papillary carcinoma and a
squamous carcinoma within the thyroid gland. The clinicopathological features and
immunohistochemical profile are reported. The theories of origin, epidemiology and management
are discussed with a literature review.
Case presentation: A 65 year old woman presented with a large thyroid swelling of 10 years
duration and with swellings on the back and scalp which were diagnosed to be a follicular variant
of papillary thyroid carcinoma with metastasis. Clinical examination, radiology and endoscopy ruled
out any other abnormality of the upper aerodigestive tract. The patient was treated surgically with
a total thyroidectomy with central compartment clearance and bilateral selective neck dissections.
The histopathology revealed a collision tumor with components of both a follicular variant of
papillary carcinoma and a squamous carcinoma. Immunohistochemical analysis confirmed the
independent origin of these two primary tumors. Adjuvant radio iodine therapy directed toward
the follicular derived component of the thyroid tumor and external beam radiotherapy for the
squamous component was planned.
Conclusion: Collision tumors of the thyroid pose a diagnostic as well as therapeutic challenge.
Metastasis from distant organs and contiguous primary tumors should be excluded. The origins of
squamous cancer in the thyroid gland must be established to support the true evolution of a
collision tumor and to plan treatment. Treatment for collision tumors should depend upon the
combination of primary tumors involved and each component of the combination should be treated
like an independent primary. The reporting of similar cases with longer follow up and will help
define the epidemiology, biology and establish standardized protocols for treatment of these
extremely rare tumors.
Background
Collision tumors within the thyroid gland are extremely
rare and reported cases have mixed histologies of follicu-
lar or papillary and medullary carcinomas [1]. The co-
existence of a follicular variant of a papillary carcinoma
and squamous carcinoma in the thyroid gland is unique.
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Detailed histopathological and immunohistochemical
studies solve the questions that pertain to the origins of
these tumors. Collision tumors such as the one presented,
especially with a component of squamous carcinoma
could denote a poor prognosis. The clinicopathological
features, theories of origin and management protocols of
these tumors are reviewed.
Case presentation
A 65 year old woman presented to the head and neck serv-
ice with a long standing goiter of 10 years duration and
recent swellings over the back and the scalp since 3
months. The thyroid swelling was slow growing with no
history of a rapid increase in the recent past. The patient's
thyroid function tests (T3, T4 and TSH) were within nor-
mal limits and she had no pressure signs and symptoms.
Her past history was non-contributory. A complete physi-
cal examination revealed a large, firm multinodular swell-
ing involving the entire thyroid gland. There was no
palpable cervical adenopathy and a review of all other sys-
tems was negative. Endoscopic and radiological (barium
swallow) examination of the upper aerodigestive tract
were normal. Her vocal cords were mobile. Examination
also revealed fluctuant swellings of the left parietal and
left thoracic paraspinal regions. An ultrasound of the neck
revealed a 7.4 cm large heterogeneous tumor of the thy-
roid with bilateral lymphadenopathy of intermediate ori-
gin at levels II and III. Fine needle aspiration cytology of
the thyroid gland and the scalp lesion confirmed a follic-
ular variant of papillary carcinoma with metastatic depos-
its in the scalp. A biopsy of the scalp lesion was not
performed in view of a conclusive diagnosis on fine nee-
dle aspiration cytology. A biopsy of the paraspinal mass
also showed a follicular variant of papillary carcinoma. An
elevated serum thyroglobulin level (>800 ng/ml) sup-
ported the thyroid origin of the primary tumor. The chest
x-ray was normal. The patient was staged as cT3 N0 M1
(Stage IVc, AJCC – TNM) [2]. The patient underwent a
total thyroidectomy with central compartment clearance
and bilateral selective neck dissections (levels II, III & IV).
At surgery, the tumor was confirmed to arise from the
gland. There were no separate lesions to suggest the pres-
ence of a thyroglossal cyst remnant or infiltration of the
thyroid gland by a primary from an adjacent organ. His-
topathology revealed a collision tumor with components
of both a follicular variant of a papillary carcinoma and a
squamous carcinoma. In view of the large tumor and dual
histology, we planned for radio iodine therapy directed
toward the follicular derived component of the thyroid
tumor and external beam radiotherapy for the squamous
component. The patient was referred for adjuvant treat-
ment but unfortunately did not follow up. At the last fol-
low on the 4th August 2005 the patient was tumor free;
three months after completion of surgical therapy.
Attempts to contact the patient via all possible resources
were futile.
Surgical pathology
Gross examination
The total thyroidectomy specimen measured 8.5 cm × 5.5
cm × 3.0 cms, with a solid, encapsulated tumor involving
the right lobe and the isthmus. On cut surface, a tan
colored fleshy tumor measuring 6.0 × 5.0 × 2.5 cms was
seen with a thin rim of thyroid parenchyma partially sur-
rounding it. Juxtaposed to this tumor was another distinct
gray-white tumor measuring 3.0 × 2.5 × 2.0 cms showing
a central irregular cystic area. The left lobe was unremark-
able. The largest node dissected was 0.8 cm in diameter
and was grossly unremarkable.
Microscopic examination
Multiple sections from the thyroid mass displayed an
invasive follicular variant of papillary carcinoma with foci
of capsular invasion. There was an obvious extrathyroidal
extension of the tumor. Juxtaposed with the papillary car-
cinoma in close proximity was an independent primary
tumour with histology of a moderately differentiated non
keratinizing squamous carcinoma. The two tumours were
separated by fibrous septae over a broad area. They inter-
mingled minimally at the interface representing a true
"collision tumor" (Figure 1, 2). The follicular variant of
papillary carcinoma showed a uniform follicular differen-
tiation without papillary areas or squamous morules.
Classical nuclear features of papillary carcinoma namely
nuclear crowding, nuclear clearing, overlapping and
grooving with irregularities of the nuclear membrane were
evident (Figure 3). These two tumors were distinct mor-
Follicular variant of papillary carcinoma of thyroid and squa- mous carcinoma in close juxtaposition with each other (H&E  200×) Figure 1
Follicular variant of papillary carcinoma of thyroid and squa-
mous carcinoma in close juxtaposition with each other (H&E 
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phologically and were also independent without a zone of
transition from papillary to squamous carcinoma. As the
squamous carcinoma was non-keratinizing in nature, ker-
atin pearls were not seen but clusters of cohesive cells with
abundant eosinophilic cytoplasm and distinct cytoplas-
mic borders were noted (Figure 4, 5). The squamous car-
cinoma revealed a large area of cystic degeneration in the
center and also showed muscle infiltration at the periph-
ery. A diligent search failed to reveal remnants of thy-
roglossal cyst or areas of anaplastic carcinoma. There was
an absence of lymphoid tissue around the component of
squamous carcinoma. The uninvolved lobe showed no
evidence of Hashimoto's thyroiditis.
One of the fourteen dissected nodes showed a focus of
metastatic papillary carcinoma (micrometastasis) without
extranodal invasion. The disease was staged histopatho-
logically as pT3 N1 M1 (Stage IVc, AJCC – TNM) [2].
Immunohistochemical profile
The components of papillary carcinoma were strongly
positive for thyroglobulin and TTF1 (Thyroid transcrip-
tion factor) while they were negative for calcitonin. The
squamous carcinoma cells were positive for cytokeratin
Tumor cells with eosinophilic cytoplasm forming a pearl Figure 5
Tumor cells with eosinophilic cytoplasm forming a pearl. 
Note the distinct cytoplasmic borders (H&E 400×).
Papillary thyroid carcinoma of the thyroid showing nuclear  crowding, nuclear clearing and nuclear grooves (H&E 200×) Figure 3
Papillary thyroid carcinoma of the thyroid showing nuclear 
crowding, nuclear clearing and nuclear grooves (H&E 200×).
Minimal intermingling of both the tumors at the interface  area without transformation (H&E 200×) Figure 2
Minimal intermingling of both the tumors at the interface 
area without transformation (H&E 200×).
Nests of non keratinizing squamous cell carcinoma (H&E  200×) Figure 4
Nests of non keratinizing squamous cell carcinoma (H&E 
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only but negative for thyroglobulin, TTF1 and calcitonin,
confirming the independent origins of the tumors.
Discussion
The term "collision tumor" refers to coexistent but inde-
pendent tumors that are histologically distinct [1]. Colli-
sion tumors can occur within the same organ or adjacent
organs or in conjunction with a systemic malignancy or as
a metastatic phenomenon [1]. Various mechanisms have
been proposed for collision tumors. The first, is a "chance
accidental meeting" of two primary tumors. Another
hypothesis suggests that the presence of the first tumor
alters the microenvironment facilitating the development
of the second primary tumor or seeding of metastatic
tumor cells. The third theory suggests a common stem cell
of origin for the two tumors [1]. Multicentricity of thyroid
carcinoma especially papillary carcinoma is not a rare
event, occurring in a range of 18% to 22% of thyroid neo-
plasms. However, the presence of morphologically and
histogenetically dissimilar primary neoplasia within the
thyroid gland is very unusual [3]. Collision tumors of the
thyroid must be differentiated from mixed and composite
tumors which show parafollicular and follicular derived
cellular elements. Mixed tumors have a common cell of
origin; tumor cells show expression of both thyroglobulin
and calcitonin. Composite tumors on the other hand,
have two discrete cellular populations – thyroglobulin
positive and calcitonin positive [3]. These definitions
automatically rule out the presence of a mixed or compos-
ite tumor in our case which has a co-existent follicular var-
iant of a papillary carcinoma and a squamous carcinoma.
The origin of squamous cells within the thyroid gland has
many theories. These can be found as a result of persist-
ence of thyroglossal duct or from a branchial pouch. They
may also arise from a squamous metaplasia in a papillary
carcinoma, anaplastic carcinoma, Hashimoto's thyroiditis
or other conditions [4,5]. There was no evidence of squa-
mous metaplasia or transformation from one tumour to
the other. The histological features of both tumours were
distinct and remained consistent in our examination. The
de novo occurrence of primary squamous cancer from fol-
licular cells has also been advocated. However, such pri-
mary squamous cancers of the thyroid are extremely rare
and account for less than 1% of all thyroid neoplasms.
Moreover the tumour cells stain positively with thy-
roglobulin. Lack of thyroglobulin positivity in squamous
carcinoma cells ruled out the possibility of follicular epi-
thelial origin in our case.
Primary squamous cancers of the thyroid gland are
innately aggressive tumors and typically present with a
high incidence of pressure symptoms (dysphagia and dys-
pnea), infiltration of the surrounding soft tissue and his-
tory of recent onset of the symptoms, usually within
weeks or months [5]. Moreover, squamous cell carcino-
mas are the commonest metastatic disease in the head and
neck [6]. Hence, it is important to rule out infiltration of
the thyroid gland from an adjacent organ and metastasis
from a distant organ before labeling a squamous cell car-
cinoma as a primary thyroid cancer. In our case, the squa-
mous cancer was restricted to the thyroid gland. Absence
of symptoms, a negative physical examination and a neg-
ative review of systems helped to exclude a metastatic
squamous carcinoma. Although metastatic squamous cell
cancers most commonly present themselves in the cervical
nodes [7], a true exclusion of a metastatic disease from
secondary sites would warrant an autopsy. In retrospect, a
histopathological examination of the scalp lesion could
have helped. Given the fact that skin metastasis especially
to the scalp from a follicular variant of papillary carci-
noma are extremely rare [8]; a finding of a pure thyroid
metastasis would have confirmed the findings in this case
and also would have excluded a possibility of a primary
cutaneous squamous cell carcinoma of the scalp with
metastasis to the thyroid.
Thyroglossal duct remnants, most typically thyroglossal
cysts, harbor carcinoma in less than 1% of cases. 95% of
these cancers are papillary carcinomas and only 5% are
squamous cancers, the latter having a worse prognosis [9].
Literature has described only two cases of concurrent pap-
illary and squamous carcinomas in the thyroglossal cyst as
yet, reflecting the rarity of this histopathological combina-
tion [10]. However, localization of a carcinoma to a
clearly demonstrable thyroglossal duct and a normal thy-
roid gland are a prerequisite to diagnose a primary thy-
roglossal cyst carcinoma [11]. These criteria rule out the
contributions of a thyroglossal duct cyst to the develop-
ment of the collision tumor in our case, as both tumors
clearly arose within the thyroid gland and remnants of
thyroglossal cyst were not seen either on preoperative
sonography or after extensive sampling of the specimen.
Metastasis to the thyroid gland is not as unusual as previ-
ously believed. The incidence of thyroid gland involve-
ment in autopsy studies ranges from 1.25% – 24.2%. The
primary tumor can usually be identified in 95% of the
cases. The presence of metastasis to thyroid indicates a dis-
seminated disease and reflects a very poor prognosis, with
average survival from diagnosis to death of 2 months.
However, a previous history of a malignancy is essential to
make this diagnosis [12]. Another source of a squamous
cell carcinoma in the thyroid could be an invasion from a
carcinoma of the larynx, tongue base or esophagus; which
commonly invade the thyroid gland [13]. A normal head
and neck examination, panendoscopy and barium swal-
low ruled out the possibility of infiltration of the thyroid
gland by a primary in an adjacent organ.World Journal of Surgical Oncology 2006, 4:65 http://www.wjso.com/content/4/1/65
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These observations validate our presentation of a collision
tumor in the thyroid composed of a squamous carcinoma
and a follicular variant of papillary carcinoma i.e. mor-
phologically different primary malignant tumors.
Even though metastatic disease of the thyroid have a poor
prognosis in general, Shaha et al, in the study of 44
patients followed for an average of 20 years, have shown
a long term survival of 43% in patients who had distant
metastasis at presentation [14]. Our patient was offered
surgery followed by radioiodine treatment. However, the
presence of a squamous carcinoma infiltrating the skeletal
muscles in this collision tumor prompted the addition of
external beam radiotherapy because squamous cell carci-
nomas of the thyroid are not known to take up radio
iodine [15]. It is well acknowledged that primary squa-
mous carcinoma of the thyroid tends to have a poor prog-
nosis and majority of the patients die within 1 year of
presentation in spite of using combination therapy
including surgery, radiotherapy and chemotherapy [16].
However on the other hand, Cook et al have shown that
long-term survival may be possible if the disease is diag-
nosed early, resected completely and treated with surgery
followed by radical radiotherapy [17]. In either case, we
feel that there is insufficient literature to extrapolate this
to predict how squamous carcinoma will behave as a com-
ponent of a collision tumor. The absence of squamous
carcinoma in the node metastasis and distant metastatic
sites suggests an overall predominance of a differentiated
thyroid cancer.
Conclusion
Collision tumors of the thyroid are extremely rare and
pose a diagnostic as well as therapeutic challenge. Metas-
tasis from distant organs and contiguous primary tumors
should be excluded. The origins of squamous cancer in
the thyroid gland must be evaluated to establish the true
evolution of a collision tumor and to plan treatment
accordingly. Treatment guidelines are poorly defined due
to the dearth of literature on this subject. Treatment for
collision tumors should depend upon the combination of
primary tumors involved and each component of the
combination should be treated like an independent pri-
mary. In this case, the slow growing tumor, larger size and
nodal metastasis suggested a predominance of the differ-
entiated thyroid cancer. Hence surgery followed by a com-
bination of adjuvant radioiodine and external
radiotherapy was justified owing to the relatively better
survival rates reported in differentiated thyroid cancer
even in the presence of distant metastasis. It is vital to
acknowledge the aggressive nature of primary squamous
cancers of the thyroid and to be vigilant in the follow up
of these patients. A short follow up is a limitation of this
report as a longer follow up would have provided the
opportunity to study the course of the disease process. The
reporting of similar cases with longer follow up will help
define the epidemiology, biology and establish standard-
ized protocols for treatment of these extremely rare
tumors.
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